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Oxidative stress is involved in the pathogenesis of several diseases such as atherosclerosis and age-related macular degeneration
(AMD). ApoE-deficientmice (apoE−/−) are awell-establishedmodel of genetic hypercholesterolemia and develop retinal alterations
similar to those found in humanswithAMD.Thus supplementationwith lutein ormultivitamin plus lutein and glutathione complex
(MV) could prevent the onset of these alterations. ApoE−/− mice (𝑛 = 40, 3 months old) were treated daily for 3 months with lutein
(AE-LUT) orMV (two doses): AE-MV15 (15mg/kg/day) andAE-MV50 (50mg/kg/day) andwere compared to controls with vehicle
(AE-C). Wild-type mice (𝑛 = 10) were also used as control (WT-C). ApoE−/− mice showed higher retinal lipid peroxidation and
increasedVEGF expression andMMP-2 activity, associatedwith ultrastructural alterations such as basal laminar deposits, vacuoles,
and an increase in Bruch’s membrane thickness. While lutein alone partially prevented the alterations observed in apoE−/− mice,
MV treatment substantially reduced VEGF levels andMMP-2 activity and ameliorated the retinal morphological alterations.These
results suggest that oxidative stress in addition to an increased expression and activity of proangiogenic factors could participate in
the onset or development of retinal alterations of apoE−/−mice.Moreover, these changes could be prevented by efficient antioxidant
treatments.
1. Introduction
Oxidative and nitrosative stress can induce alterations in
DNA, proteins, and lipids, and extensive data suggest that
oxidative damagemay play amajor causal role in a number of
human diseases such as atherosclerosis, cancer, and cataracts
as well as retinal pathologies such as age-related macular
degeneration (AMD) [1, 2]. Currently, AMD is the most
common cause of severe and irreversible blindness in Europe
and the United States in people older than 65 years, and
its prevalence is expected to increase as the population ages
[3, 4]. The pathogenesis of AMD is unclear; however, several
mechanisms influenced by genetic, systemic health, and
environmental risk factors have been proposed. Numerous
studies have also shown a relationship between cardiovas-
cular disease and AMD, although others have not been able
to verify this correlation. Dietary fat, in particular, choles-
terol, is positively linked to increased incidence of coronary
heart disease (CHD), and evidence suggests that abnormal
lipid levels may contribute to the development of AMD,
either directly or through the promotion of vascular disease
[1, 2, 5].
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Animal models attempting to recreate AMD through
phototoxicity, senescence acceleration, candidate gene
manipulation, and high-fat diets do not fully replicate the
clinical, histologic, and angiographic features of the human
condition, probably because of the multifactorial aspect of
the disease [6]. The histopathology of early AMD reveals
accumulation of specific lipid-rich deposits under the retinal
pigment epithelium (RPE) [7]. Moreover, as it has been
postulated on the hypothetical model of RPE oxidant injury,
matrix metalloproteinases could participate in extracellular
matrix (ECM) turnover in Bruch’s membrane (BM) [8].
Degenerative changes of the RPE and photoreceptor cells are
early events in AMD [9], and it has been demonstrated that
apoE deficiency predisposes to ultrastructural changes in
BM [10]. Apolipoprotein E-deficient mice (apoE−/−) develop
spontaneous hypercholesterolemia in a few weeks [11] and
also display morphological and ultrastructural alterations
in RPE [10, 12, 13] similar to those in human AMD. Based
on functional and structural analyses, the apoE−/− mouse
constitutes a valuable tool in elucidating the underlying
mechanism of retinal degeneration [13].
Lutein and zeaxanthin are essential carotenoids that need
to be obtained from certain vegetables, such as spinach,
corn, pumpkin, and egg yolk [14]. They accumulate in the
retina, where they play an important role in maintaining
visual sensitivity and protecting against light-induced retinal
damage [15, 16]. In the retina, lutein and zeaxanthin coexist
with large amounts of polyunsaturated fatty acids that are
highly susceptible to oxidation suggesting that antioxidants
could prevent degenerative pathologies in which oxidative
stress is of high importance such as AMD [17–20]. Our
group previously showed an increase in oxidative processes
related to the retinal morphological alterations observed in
apoE−/− mice and other models of hypercholesterolemia.
Furthermore, we have reported the protective effect of antiox-
idants, such as vitamins C and E, lutein, egg yolk, and a
multivitamin-mineral complex on retinal oxidative stress and
hypercholesterolemia-derived ultrastructural alterations in
apoE−/− mice [21–24].
The aim of the present study was to investigate the
effect of lutein and a multivitamin complex with lutein
and glutathione on systemic and retinal biochemical and
ultrastructural parameters in apoE−/− mice.
2. Material and Methods
2.1. Experimental Design. Ten 3-month-old male mice
C57BL/6 and forty apoE−/− mice were used for this study.
Progenitor coupleswere obtained from “Center for Transgene
Technology and Gene Therapy,” Flanders Interuniversity
Institute for Biotechnology, Leuven (Belgium). All exper-
imental procedures followed the Guidelines for the Use
of Animals in Association for Research in Vision and
Ophthalmology (ARVO) and were approved by the Animal
Research Ethics Committee of the Universidad de Navarra.
Animal welfare was applied during all experimental process
and animals were euthanized by CO
2
inhalation according
to ethics guidelines.
Animals were randomly divided into five experimental
groups (𝑛 = 10), fed a standard rodent chow (9605/8, Harlan
Teklad TRM, Madison, WI, USA) water ad libitum for 90
days, and housed in cages in a temperature-controlled room
(20–22∘C) with a 12-hour light/dark cycle. The five study
groups were as follows: wild type (WT-C) and apoE−/− (AE-
C) receiving vehicle; apoE−/− (AE-MV15) mice receiving
15mg/kg/d of multivitamin-mineral, glutathione and lutein
complex (providing 0.027mg/kg/day of lutein) (composition
in Table 1); apoE−/− (AE-MV50) mice receiving 50mg/kg/d
of multivitamin-mineral, glutathione and lutein complex
(providing 0.086mg/kg/day of lutein); and apoE−/− (AE-
LUT) mice receiving 0.093mg/kg/d lutein. Multivitamin
treatment was administered according to the approved reg-
imen for humans.
The treatments were emulsified in a mixture of
water : soybean oil : Tween-80 (1 : 1 : 0.02; v : v : v) and admin-
istered daily by gastroesophageal cannula for 3 months
(100 𝜇L). Purified lutein was kindly provided by Dr.
Christine Gartner (Cognis, Germany), and multivitamin
complex, Nutrof, was a kind gift by Laboratorios Thea
(Barcelona, Spain).
At the beginning and end of the treatment, eyes were
examined by indirect fundoscopy with a 78-diopter lens and
0.5% cycloplegic eye drops. No retinal alterations were found
in any group.
2.2. Lipid Plasma Analysis. Blood samples were collected
after mice were killed and plasma obtained after separating
the red blood cells by centrifugation (2,600 g, 10min, 4∘C)
and were immediately frozen in liquid nitrogen and stored at
−80∘C. Concentrations of plasma total cholesterol (TC) and
triglycerides (TG) were measured following the manufactur-
ers’ instructions (SigmaChemical Co., St. Louis,MO), using a
microplate ELISA reader and calculated from the linear range
of standards.
2.3. Retinal and RPE-Choroid Homogenates Preparation.
Immediately after blood collection, eyes were enucleated and
transferred to a saline solution (pH 7.4). Retinas were rapidly
dissected by making a small incision with a scalpel 1mm
behind the limbus and extending the incision through 360∘
using fine ophthalmic scissors. Anterior segment structures
(cornea, iris, and lens) were removed. RPE-choroid samples
were homogenized with a Teflon pestle in lysis buffer (RIPA
buffer) and centrifuged for 20 minutes at 13,000 rpm at 4∘C.
Supernatant was collected and protein concentration was
determined by Bradford assay with slight modification [21,
24].
2.4. Lipid Peroxidation in Plasma and Retinal Homogenates
Based on Measurement of Thiobarbituric Acid Reactive Sub-
stances. Thiobarbituric acid reactive substances (TBARS)
were measured in plasma and retinal homogenates as an
index of oxidative stress, increasing the sensitivity by using
a fluorometric modification of the method of Conti et al. as
described [25]. Valueswere corrected by total protein content.
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Table 1: Daily dose per body weight of substances in the multivitamin-mineral complex.
100 g 15mg/kg/day (𝜇g) 50mg/kg/day (𝜇g)
Vitamins
Vitamin A 71.7mg 0.32 1.08
𝛽-carotene 0.4 g 1.8 6
Vitamin C (ascorbic acid) 10.7 g 48.15 160.5
Vitamin E (d-𝛼-tocopherol) 1.8 g 8.1 27
Vitamin B1 (thiamin) 250.8mg 1.13 3.78
Vitamin B2 (riboflavin) 286.6mg 1.3 4.33
Vitamin B3 (niacin) 3.2 g 14.4 48
Vitamin B6 (pyridoxine) 358.3mg 1.61 5.37
Vitamin B9 (folic acid) 35.8mg 0.16 0.54
Vitamin B12 (cyanocobalamin) 179.2 𝜇g 0.00081 0.00269
Oligoelements
Zinc (Zn) 1.3 g 5.85 19.5
Magnesium (Mg) 1.8 g 8.1 26.9
Manganese (Mn) 179.2mg 0.81 2.69
Selenium (Se) 4.5mg 0.02 0.066
Others
Glutathione 179.2mg 0.81 2.69
Lutein 179.2mg 0.81 2.69
Data per 100 g of product are shown as mg and for daily dose in 𝜇g. Calculation based on a 30 g mouse.
2.5. Measurement of Total Nitrites and Nitrates as an Indirect
Indicator of NO Synthesis. Nitric oxide (NO) is oxidized
rapidly in biological tissues, firstly to nitrites and secondly
to nitrates. Determination of nitrites (NO
2
−) and nitrates
(NO
3
−) is an indirect indicator of NO synthesis. Method-
ology employed for nitrites and nitrates measurement was
adapted from Archer and Marzinzig [26, 27] with slight
modifications. Briefly, samples were deproteinized with sul-
fosalicilic acid (25%), mixed with 5𝜇L NaOH 1M to arise
pH 7,6, and centrifuged for 10 minutes (10,000 g). Standard
curve was prepared with NaNO
3
and ranged between 0 and
30 𝜇M. Fourteen mU of nitrate reductase (NADPH 40 𝜇M
and FAD 1 𝜇M in Tris 20mM; pH 7,6) were added to 10 𝜇L of
supernatant. Samples were developed by adding diaminon-
aphthalene (DAN) 0.1mg/mL and reaction was stopped
with NaOH 2.8mM. Fluorescence at 410 nm was read in
a microplate reader (POLARstar Galaxy, BMG LABTECH
GmbH) after excitation at 380 nm.
2.6. Western Blotting for Vascular Endothelial Growth Factor
(VEGF). Equal amounts of RPE-choroid homogenates (5𝜇g)
were mixed with Laemmli buffer (62.5mMTris-HCl, pH 6.8;
2% SDS; 10% glycerol; 0.1% bromophenol blue) and boiled
for 5min. Samples were separated on 12% SDS-PAGE gels
and transferred to a nitrocellulose membrane. After blocking
with 5% skimmed milk (w/v), 0.1% Tween-20 (w/v) in TBS
for 1 hour at room temperature, membranes were exposed
to the primary antibody (0.2 𝜇g/𝜇L, monoclonal anti-VEGF,
sc7269, Santa Cruz Biotechnology Inc., Santa Cruz, CA)
at room temperature for 1 hour followed by incubation
with a horseradish peroxidase-conjugated goat antimouse
antibody (sc2005; 0.4 𝜇g/𝜇L, Santa Cruz Biotechnology Inc.).
Signals were detected with an enhanced chemoluminescence
(ECL) kit (ECL western blotting detection kit, GE Health-
care, Fairfield, CT) and exposure to autoradiographic film
(Hyperfilm ECL, GE Healthcare). The relative intensities of
the immunoreactive bands were analyzed with Quantity One
software (version 4.2.2, Bio-Rad Laboratories, Hercules, CA).
The loading was verified by Ponceau S red, and the same blot
was stripped and reblotted with an anti-𝛽-actin monoclonal
antibody (Sigma-Aldrich) to normalize the VEGF level.
2.7. Gelatin Zymography Assay for Matrix Metalloproteinase-2
(MMP-2) Activity. MMP-2 activity was quantified by gelatin
zymography on RPE-choroid homogenates [28]. Eight 𝜇g
of total protein from homogenate supernatants were mixed
with nonreducing sample buffer (62.5mM Tris-HCl, pH 6.8;
10% glycerol; 0.1% bromophenol blue) and electrophoresed
directly on 9% SDS-polyacrylamide gels (SDS-PAGE) con-
taining 0.1% gelatin (w/v). After electrophoresis, gels were
washed 4 times for 20 minutes at room temperature in a
2.5% (v/v) Triton X-100 solution to remove excess of SDS,
transferred to a solution (zymogramdevelopment buffer, Bio-
Rad), and incubated for at least 18 hr at 37∘C. Protein fixation
was developed by incubating gels for 15 minutes with 50%
methanol/7% acetic acid and then washing for 30 minutes
(6 times of 5 minutes each) with distilled water. After that,
gels were stained for 1 hour with GelCode Blue Stain Reagent
(Pierce, Rockford, USA) counterstained with distilled water
and then analyzed with Quantity One software (version 4.2.2,
Bio-Rad) after densitometric scanning of the gels. The active
MMP-2/(active MMP-2 + proMMP-2) intensity ratio was
designated as the MMP-2 activation ratio. Each zymography
assay was repeated at least three times to ensure accuracy.
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2.8. Electron Microscopy. Three or four eyes from each group
were processed for histological examination. The whole
enucleated murine eyes were fixed in 2.5% glutaraldehyde,
0.1mol/L cacodylate, 0.2mol/L PBS. The posterior pole was
dissected as described above and postfixed in 1% osmium
tetroxide, stained with 1% uranyl acetate, and embedded
in Epon Araldite resin. One-micrometer sections were cut
with an ultramicrotome, stained with 2% toluidine blue O,
and examined under a light microscope to determine the
areas of interest. Thin sections (approximately 50–90 nm)
were cut, collected on copper grids, and stained with 4%
uranyl acetate and lead citrate. Subsequently, three sections
from each animal were evaluated by transmission electron
microscopy (TEM) (EM10, Carl Zeiss, Thornwood, NY) and
photographed for posterior analysis. For semiquantitative
scoring, 2-3 representative high-power micrographs were
made of each low-power section. The high-power micro-
graphs were graded by two independent examiners unaware
of the experimental procedures.The variables evaluated were
as follows: frequency of BLamD, BM thickness, presence of
vacuoles in RPE, presence of vacuoles and lucent areas in
BM, and presence of deposits of amorphous material in the
RPE. BM thickness was directly measured in three different
standardized locations in each image and averaged to provide
a mean score for that micrograph. The mean of high-power
micrographs was used to assign an average BM thickness
for an individual specimen (𝜇m). The remaining variables
were graded following previous score grading method [24,
29] with slight modification: absence (−), any (+), mod-
erate (++), and severe presence (+++). In addition, the
frequency of BLamD was classified as follows. “Any BLamD”
was defined as the presence of any discrete focal nodule
of homogenous material of intermediate electron density
between the RPE cell membrane and BM in at least one
micrograph. “Severe BLamD” was defined as the presence,
in at least three micrographs, of the following: continuous
BLamD extending under two or more cells, deposit thickness
equal to or greater than 20% of RPE cell cross-sectional
thickness.
2.9. Statistical Analysis. Values are reported throughout as
the mean ± the standard error of the mean (SEM). Statistical
significance for biochemical parameters and BM thickness
was determined applying analysis of variance (ANOVA)
or Kruskal Wallis test to assess differences among groups.
After a significant ANOVA or Kruskal Wallis, comparisons
between groups were made with Bonferroni posthoc or
Mann Whitney test, respectively. Statistical significance was
accepted at the 95% confidence level (𝑃 < 0.05), and analysis
was performed by using the computer program SPSS (v. 15.0,
SPSS Inc. Chicago, USA).
3. Results
3.1. ApoE−/− Mouse Weight and Lipid Profile. Table 2 sum-
marizes the general characteristics of the different animal
groups. AE-C weight was higher than WT-C weight (𝑃 <
0.05), and apoE−/− phenotype was confirmed by measuring
Table 2: Body weight, TC, and TG of the different animal groups at
the time of sacrifice.
Body weight TC TG
WT-C 28.3 ± 3.3 69.9 ± 9.5 83.2 ± 11.6
AE-C 35.6 ± 3.7∗ 624.7 ± 169.0∗∗∗ 123.4 ± 15.0∗
AE-MV15 34.3 ± 2.8∗ 675.7 ± 142.6∗∗∗ 104.7 ± 21.1
AE-MV50 34.4 ± 2.4∗ 663.1 ± 161.4∗∗∗ 86.4 ± 30.7†
AE-LUT 35.6 ± 2.3∗ 675.7 ± 189.9∗∗∗ 137.6 ± 53.3
Data are expressed as g (body weight) and mg/dL (TC and TG) ± S.D.
Statistically significant differences fromWT-C are marked as ∗𝑃 < 0.05 and
∗∗∗
𝑃 < 0.001 and from AE-C as †𝑃 < 0.05. (𝑛 = 8–10).
Table 3: Plasma and retinal lipid peroxidation of the different
animal groups at the time of sacrifice.
TBARS plasma TBARS retina NO retina
WT-C 1.22 ± 0.06 3.02 ± 0.33 11.03 ± 1.18
AE-C 1.66 ± 0.10∗∗ 8.72 ± 0.78∗∗ 5.91 ± 0.85∗∗
AE-MV15 1.32 ± 0.08† 4.77 ± 0.43†† 2.13 ± 0.27†
AE-MV50 1.25 ± 0.11† 6.58 ± 0.67† 3.64 ± 0.48†
AE-LUT 1.57 ± 0.08 7.83 ± 0.36 2.21 ± 0.90†
Data are expressed as 𝜇M malondialdehyde (MDA; TBARS plasma), nmol
MDA/mgprotein (TBARS retina), and nmol nitrates/mg protein (NO retina)
media ± S.E.M. Statistically significant differences from WT-C are marked
as ∗𝑃 < 0.05 and ∗∗𝑃 < 0.01 and from AE-C as †𝑃 < 0.05 and ††𝑃 < 0.01
(𝑛 = 8–10).
plasmaTC. PlasmaTC andTG in theAE-Cwere significantly
higher (𝑃 < 0.001 and 𝑃 < 0.05, resp.) than in WT-C mice
(Table 2).
All mice had similar weight evolution during treatment,
and treatments did not modify mice weight. Also, diet
supplementation with nutritional supplement or lutein did
not modify TC in apoE−/− mice, showing that the effects
observed in this study were independent of cholesterol
concentration modifications. Nutritional supplementation in
diet, in addition to not increasing plasma TC concentration,
induces a decrease in TG concentration in apoE−/−mice (𝑃 <
0.05). Lutein supplementation did not significantly modify
TG levels (Table 2).
3.2. Plasma and Retinal Lipid Peroxidation. AE-C animals
showed an increase in plasma and retinal lipid peroxidation
(𝑃 < 0.01), as assessed by TBARS production, compared with
WT-C (Table 3).
Both doses of nutritional complex (MV) induced a reduc-
tion in systemic and retinal lipid peroxidation (𝑃 < 0.05 and
𝑃 < 0.01) to values similar to control group (Table 3). AE-
LUT animals did not show statistical differences regarding
lipid peroxidation when compared to AE-C group (Table 3).
3.3. NO in Retina. Retinal NO synthesis was lower in AE-
C compared with WT-C animals (𝑃 < 0.01, Table 3). All
treatments administered were able to significantly (𝑃 < 0.05,
Table 3) reduce NO synthesis compared to AE-C group.
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Table 4: The effect of the different treatments on RPE and BM deposit severity, vacuolization, and BM thickness.
WT-C AE-C AE-MV15 AE-MV50 AE-LUT
BM thickness 0.45 ± 0.03∗∗ 1.08 ± 0.05 0.78 ± 0.07 0.58 ± 0.04∗ 0.75 ± 0.06
Frequency of images with evidence of BLamD − +++ ++ + ++
Presence of lucent areas in BM − ++ + − +
Vacuolization in RPE − +++ + + +
Absence (−), any (+), moderate (++), and severe (+++) presence. BM thickness shown in 𝜇m (mean ± SD). ∗𝑃 < 0.05 and ∗∗𝑃 < 0.001 versus AE-C (𝑛 = 3-4
for each group).
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Figure 1: Changes in VEGF protein expression in RPE-choroid
homogenates, reported as percentage increase with respect to
untreated wt mice. Augmented VEGF protein in apoE−/−, assessed
by western blot (densitometric analysis and representative blot
showing the 25 kDa VEGF monomer), is reduced in apoE−/− MV-
50. 𝛽-actin was used as load control. Differences from WT-C are
marked as ∗𝑃 < 0.05 and from AE-C as †𝑃 < 0.05 (𝑛 = 6-7).
3.4. VEGF Expression in ApoE−/− Mouse and the Effect
of Supplementation. Western blot with anti-VEGF antibody
revealed an almost 3-fold increase in the AE-C group in
comparison to WT-C (𝑃 < 0.05, Figure 1).
AE-MV50 mice showed VEGF protein levels similar to
WT-C (𝑃 < 0.05 versus AE-C, Figure 1). AE-LUT and
AE-MV15 had a marginal reduction when compared to
AE-C animals, but this difference did not reach statistical
significance.
3.5. MMP-2 Activity in ApoE−/− Mouse and the Effect of
Supplementation. Zymography analysis of total RPE-choroid
homogenates showed that MMP-2 activity increased in AE-
C groups when compared to WT-C tissues (𝑃 < 0.01,
Figure 2). Gelatinase activity was significantly (𝑃 < 0.01)
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Figure 2: Zymogram analysis of MMP-2 activity in RPE-choroid,
reported as percentage increase with respect to untreated wt mice.
Eyecups homogenates of apoE−/− mice showed an increase in gelati-
nase activity in comparison to WT-C mice. Mutivitamin treatment
(AE-MV50) reducedMMP-2 activity back to control levels. AE-LUT
and AE-MV15 groups exhibited a little but no significant reduction.
Differences from WT-C are marked as ∗∗𝑃 < 0.01 and from AE-C
as ††𝑃 < 0.01 (𝑛 = 6-7).
reduced in the AE-MV50 group compared with AE-C. AE-
MV15 (𝑃 = 0.062) and AE-LUT (𝑃 = 0.072) animals did not
show statistically significant MMP-2 activity modification,
although a reduction was observed (Figure 2).
3.6. Ultrastructural Alterations in ApoE−/−Mice and the Effect
of Supplementation with Lutein and Multivitamin Complex.
None of the eyes examined microscopically showed any type
of drusen or neovascularization, but some alterations were
observed in apoE−/−mice (see below). ApoE−/−mice showed
basal laminar deposits, vacuoles, and an increase in BM
thickness. While lutein alone partially prevented the alter-
ations observed in apoE−/−mice, MV treatment substantially
ameliorated the retinal morphological alterations. Figure 3
depicts photomicrographs of retinal cross sections from rep-
resentative mice of WT-C and AE-C groups, Figure 4 shows
representative images of the AE-treated groups, and Table 4
summarized the score grading for microscopic parameters
analyzed.
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Figure 3: Transmission electron micrographs of the outer retina and choroid of WT-C (a, b) and AE-C (c–j) groups (𝑛 = 3-4). Photographs
of wt mice reveal no accumulation of sub-RPE deposits, with normal RPE basal infoldings and BM ((a) ×2, 250 and detail in (b) ×4, 250).
In contrast, apoE−/− control mice show some ultrastructural alterations like vacuolization in RPE (white arrow), swelling of basal infoldings
(black arrow), subRPE electrodense deposits (black asterisk) ((c) ×1, 200 and detail in (d) ×5, 250), and opening of intercellular junctions ((e)
×2, 500 and detail in (f), ×5, 250; white arrow). Also, electrodense material, seeming BLamD (black asterisk) is observed in RPE ((g) ×2, 500
and details in (h) ×10, 000) combined with some amorphous electro-dense material (black arrow). BM thickening is evident compared with
WT-C animals, and non-membrane-bound lucent vacuoles inside BM were present ((i) ×3, 975 and (j) ×7, 725; black arrow).
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Figure 4: TEM from apoE−/− animals supplemented with the different treatments. AE-MV15 ((a) ×2, 500 and (b) ×10, 000) and AE-LUT ((e)
×5, 250 and (f) ×7, 725) animals showed less confluent and more diffuse BLamD and less lucent areas in BM, whereas those alterations were
almost absent in AE-MV50 mice ((c) ×5, 250 and (d) ×7, 725).
WT-C mice showed normal RPE and BM features. RPE
nuclei were rounded and displayed straight borders. The BM
structurewas conserved. TEMof the outer retina and choroid
revealed no accumulation of sub-RPE deposits with normal
basal infoldings, BM, and choriocapillaris (Figures 3(a) and
3(b)).
Compared with WT-C, AE-C mice showed ultrastruc-
tural changes (Figures 3(c)–3(j)). Low-power micropho-
tographs revealed a disruption of cellular components and
disorganized structure (Figures 3(c) and 3(e)). Also, eyes
from AE-C mice had an increase in the number and
size of empty and autophagocytic cytoplasmic vacuoles
(Figure 3(d)) and, as previously reported [10, 13, 30, 31], basal
laminar deposits-like (BLamD-like) structures located in the
extracellular space between the basal lamina of the RPE and
the inner collagenous layer of BM (Figures 3(c), 3(d), 3(g),
and 3(h)). Moreover, most of RPE cells analyzed exhibited
swelling of basal infoldings and opening of intercellular space
junctions between RPE cells (Figures 3(e) and 3(f)). We
also observed abnormal deposits of electrodense amorphous
material in the subRPE space confined to a small area located
to the RPE side of BM (Figures 3(d), 3(f), and 3(h)), as well
as areas of increased thickness in BM (Figures 3(i) and 3(j)).
The thickness of BM was statistically significantly higher in
AE-C group than in WT-C (Table 4, 𝑃 < 0.001). The BM
of AE-C exhibited lucent non-membrane-bounded vacuoles
dispersed through both collagenous layers (Figures 3(i) and
3(j)).
In contrast with the apoE−/− untreated animals, mice
fed with the MV complex exhibited less severe structural
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alterations in RPE and BM, with less swelling of basal
infoldings and less cytoplasm vacuoles in the RPE and in
BM. Mice supplemented with the low dose of multivitamin
complex (AE-MV15; Figures 4(a) and 4(b)) and lutein (AE-
LUT; Figures 4(e) and 4(f)) still showed moderate presence
of BLamD in RPE, which were absent in AE-MV50 ani-
mals (Table 4, Figures 4(c) and 4(d)). BM thickening in all
groups supplemented was less pronounced compared to AE-
C animals. However, only in AE-MV50 group a statistically
significant reduction was observed (Table 4, 𝑃 < 0.05).
4. Discussion
In this study we examined the utility of apoE−/− mice as a
model for AMD-like retinal degeneration and the effects of
antioxidant treatments on the phenotypical and biochemical
changes observed in this model.Themost important findings
are the increased VEGF expression and MMP-2 activity in
the RPE-choroid of apoE−/− mice and the corresponding
decrease in VEGF levels andMMP-2 activity after high doses
of a multivitamin complex with lutein and glutathione. In
addition, multivitamin supplementation reduced systemic
and retinal oxidation and ameliorated the pathological AMD-
like changes in apoE−/− mice. The fact that lutein and the
multivitamin complex prevented biochemical and morpho-
logic changes strongly suggests that hypercholesterolemia-
derived oxidative stress is at least partly responsible for the
alterations.
Based on biochemical and structural analyses, the
apoE−/−mouse is a valuable tool in elucidating the underlying
mechanism of retinal degeneration. ApoE−/− mice accrued
marked increases in plasma TG and TC that were associated
with increased systemic oxidative status. TG levels were
reduced in animals supplemented with high-dose multivi-
tamin complex, and this reduction may contribute, at least
in part, to systemic oxidative stress decrease. We and others
have reported evidence of systemic oxidative stress in apoE−/−
mice [22–24], and our group has previously demonstrated
that systemic and retinal oxidative stress in apoE−/− mice is
reduced by dietary antioxidants present in egg yolk [23] and
zeaxanthin [22].Moreover, vitamins C and Ewere effective in
reducing oxidative and nitrative stress in apoE−/− mice [24]
and in a model of porcine dietary hypercholesterolemia [21].
VEGF can be regulated by hypoxia, oxidative stress, and nitric
oxide [32]. Matrix metalloproteinases (MMPs) are involved
in extracellular matrix remodelling. Both VEGF and MMPs
are regulated, at least in part, by oxidative stress [33, 34];
thus, it is relevant to study their activation and expression in
pathologies where oxidative stress seems to play an important
role.
In the present work we observed a reduction in total
NO production in the retinas of apoE−/− mice compared
to wild-type animals which could be a consequence of
a reduced nNOS activity and, subsequently, reduced NO
production [35]. In our study, the treatments groups showed
NO reduction compared to apoE−/− controls. It is possible
that the decrease or increase in reduced glutathione (GSH)
concentration (as a consequence of supplement adminis-
tration) is able to alter the effects of NO (GSH forms
adducts with NO: S-nitrosoglutathione) without affecting the
expression of NOS [36]. It has been demonstrated that GSNO
and NO protect neurons from hydroxyl radical-induced
oxidative stress in vivo by terminating lipid peroxidation and
augmenting the antioxidative potency of GSH, among other
effects [37]. Therefore, restoring GSH levels can help NO to
exert its beneficial effects, whereas the decrease in GSH levels
could enhance the neurotoxic effects of free NO. Alterations
in NO synthesis and bioavailability not only activate growth
factors as VEGF but also induce physiological changes such
as vasoconstriction and decreased choroidal flux. Increased
oxidative stress in apoE−/− mice could result in an excess
of O
2
∙−, which would react with NO to form ONOO−,
decreasing NO bioavailability. However, the methodology
employed in the present study did not permit us to evaluate
NO bioavailability in genetic hypercholesterolemia.
ApoE−/− mice showed an increase in VEGF expression
and MMP-2 activity in the RPE compared to wild-type-
animals, probably produced in response to high oxidative
stress environment. VEGF expression is regulated partly
by oxidative stress or NO and hypoxia in RPE cells [38].
Our results agree with those obtained in apoE−/− mice
aortas showing an increase in gelatinase activity, VEGF,
and VEGFR2 compared to controls [39, 40]. VEGF and
MMPs can positively regulate each other [41]. An increase
in VEGF expression in RPE has been previously reported by
us; however, to our knowledge this study is the first showing
an increasedMMP-2 activity in posterior eyecups of apoE−/−
mice. It is possible that the augmented VEGF expression
and MMP-2 activity in apoE−/− mice could be derived, at
least partly, from the increased oxidation observed in the
retinal environment, where the presence of free radicals could
stimulate cytokine or growth factors production.
GSH and its related enzymes are part of the antioxidant
defense against oxidative stress elevation. GSH depletion
occurs in several forms of cell death, including in the retina
[42, 43]. In rd1 mice it has been demonstrated that antioxi-
dant supplementation (lutein, zeaxanthin, 𝛼-lipoic acid, and
GSH) prevents photoreceptor apoptosis and DNA oxida-
tive damage. When administered individually, none of the
antioxidants produced a significant decrease in the number
of apoptotic cells or DNA damage level in photoreceptors
[44]. These results agree with ours in showing a decrease
in retinal lipid peroxidation, VEGF, and MMP-2 activity in
animals supplemented with the mixture of antioxidants with
lutein and GSH but no significant modifications in animals
supplemented with lutein alone. Our group demonstrated
the decrease of superoxide anion as well as retinal lipid
peroxidation by vitamins C and E oral administration in
hypercholesterolemic porcine RPEs [21]. That result con-
firmed the association of retinal lipid peroxidation and
changes in reactive oxygen species synthesis and could be
the same mechanism in apoE−/− mice and the multivitamin
complex.
This is the first study showing a decrease in VEGF
expression and MMP-2 activity in the retina after nutritional
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supplementation in the apoE-deficient mouse. According to
the most recent review on lutein [45], there is only one study
that demonstrated a reduction in VEGF after lutein supple-
mentation where Izumi-Nagai et al. [46] showed a reduction
of VEGF in RPE protein extracts from a murine model of
choroidal neovascularization. Their experimental setting is
completely different fromourmodel; luteinwas administered
only during 6 days (3 days before laser photocoagulation and
3 days afterwards), while our treatment lasted for 3 months.
Moreover, to the best of our knowledge, there is only one
paper showing a decrease in VEGF expression in ARPE-19
cells after TNF-alpha stimulation [47].
To determine whether the biochemical changes are
accompanied by retinal ultrastructural alterations, we per-
formed limited electron microscopy analyses. In the future,
extensive examination of several eye cross sections will
render a more accurate depiction of eye-wide morphological
changes. Nevertheless, our electron microscopy evaluation
shows that apoE−/− mice develop several ultrastructural
alterations. BLamDs, defined as amorphous electron-dense
material among the basal infoldings on the RPE side of BM,
were present as previously reported [10, 22–24]. We observed
ultrastructural changes in the BM of apoE−/− similar to
those reported by Dithmar et al. [10]. BLamD was more
dispersed, and the sub-RPE layer contained far less electron-
dense material in animals supplemented with multivitamin
complex than in the controls or the untreated groups. The
impact of dietary antioxidants on BLamD is consistent with
reports that increased exposure to oxidation (e.g., inhalation
of cigarette smoke and exposure to photooxidative stress)
induces increased formation of BM deposits [29, 48]. Lipid
peroxidation is likely one of many potential stimuli of injury,
and it is possible that BLamD formation reflects a final
common pathway of reparative processes shared by many
cellular types in response to injury [49]. Our results strongly
suggest that the reduced quantity of BLamD in the 6-month-
old AE-MV50 retinas resulted from increased turnover or
reduced formation of BLamD. Furthermore, we demonstrate
an increase in BM thickness in apoE−/− mice, that is, reduced
by supplementation with antioxidants, lutein and GSH. The
results obtained in this animal model agree with those
showed in a porcine model of dietetic hypercholesterolemia
[21] and with the observations in other models of retinal
degeneration such as rd1 mice [44]. Our hypothesis is
that the hypercholesterolemic status of apoE−/− mice may
have contributed significantly to the retinal abnormalities,
probably mediated by an increase in oxidative stress.
Moreover, this hypothesis is supported by the fact that
those mice supplemented with multivitamin complex did
not show these characteristic features. Therefore, these com-
pounds could play a role in protection of oxidative stress-
derived damage in the retina. This could be considered in
preventive therapy for ocular degenerative pathologies, as
a mean to improve life quality in patients. The reduction
of VEGF expression and MMP-2 activity, accompanied by
oxidative stress reduction, could be one of the mecha-
nisms underlying the reduction in ultrastructural alterations.
When lutein is combined with other antioxidant substances,
beneficial effects are observed in hypercholesterolemia oxida-
tive stress-derived changes. Although our study did not estab-
lish a causal relationship between phenotypical and biochem-
ical findings, the latter can be associated with cytoplasmic
and BM ultrastructural alterations. The increase in VEGF
expression could be responsible for the increased permeabil-
ity in choroid and BM, and MMP-2 activity could degrade
BM, leading to the observed thickening and vacuolization.
MMPs are enzymes involved in synthesis and degradation
of extracellular matrix and have specific substrates such as
collagen and elastin, both of themBM components. RPE cells
are subsequently stimulated to increase synthesis of MMPs
and othermolecules responsible for ECM turnover. Increased
matrix turnover is characterized by increased MMPs and
decreased collagens [8]. As these morphological changes are
ameliorated with supplementation with antioxidants, it is
probable that oxidative stress increase is the initiating factor
for the molecular and morphological changes in apoE−/−
mice.
5. Conclusions
This study provides data suggesting an evolving role for
hypercholesterolemia in the development of retinal oxidative
stress and the influence of dietary fat in ultrastructural
RPE changes. Furthermore, VEGF and MMP-2 are respon-
sible, at least in part, for some of the changes caused by
hypercholesterolemia-derived oxidative stress. Additionally,
supplementation with lutein, glutathione, and a complex of
vitamins appears to be effective in reducing these retinal
changes. However, further experimental, epidemiological
and clinical studies are required to confirm these findings.
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